3-Methylsalicylic acid structure
|
Common Name | 3-Methylsalicylic acid | ||
---|---|---|---|---|
CAS Number | 83-40-9 | Molecular Weight | 152.147 | |
Density | 1.3±0.1 g/cm3 | Boiling Point | 293.2±28.0 °C at 760 mmHg | |
Molecular Formula | C8H8O3 | Melting Point | 98-100 °C(lit.) | |
MSDS | Chinese USA | Flash Point | 145.4±20.5 °C | |
Symbol |
GHS05, GHS07 |
Signal Word | Danger |
Use of 3-Methylsalicylic acid3-Methylsalicylic acid is a salicylic acid derivative compound with marked fibrinolytic activity in human plasma by activating its fibrinolytic system. |
Name | 3-Methylsalicylic acid |
---|---|
Synonym | More Synonyms |
Description | 3-Methylsalicylic acid is a salicylic acid derivative compound with marked fibrinolytic activity in human plasma by activating its fibrinolytic system. |
---|---|
Related Catalog |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 293.2±28.0 °C at 760 mmHg |
Melting Point | 98-100 °C(lit.) |
Molecular Formula | C8H8O3 |
Molecular Weight | 152.147 |
Flash Point | 145.4±20.5 °C |
Exact Mass | 152.047348 |
PSA | 57.53000 |
LogP | 2.52 |
Vapour Pressure | 0.0±0.6 mmHg at 25°C |
Index of Refraction | 1.600 |
Storage condition | -20?C Freezer |
Water Solubility | 1.5 g/L (20 ºC) |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
Symbol |
GHS05, GHS07 |
---|---|
Signal Word | Danger |
Hazard Statements | H302-H315-H318-H335 |
Precautionary Statements | P261-P280-P305 + P351 + P338 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Faceshields;Gloves |
Hazard Codes | Xn:Harmful |
Risk Phrases | R22;R41 |
Safety Phrases | S26-S36/39-S22 |
RIDADR | UN 2811 |
WGK Germany | 3 |
RTECS | BZ4385000 |
HS Code | 2918290000 |
Precursor 9 | |
---|---|
DownStream 10 | |
HS Code | 2918290000 |
---|---|
Summary | HS: 2918290000 other carboxylic acids with phenol function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids and their derivatives Tax rebate rate:9.0% Supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward) VAT:17.0% MFN tariff:6.5% General tariff:30.0% |
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
J. Med. Chem. 54 , 591-602, (2011) Fragment-based lead design (FBLD) has been used to identify new metal-binding groups for metalloenzyme inhibitors. When screened at 1 mM, a chelator fragment library (CFL-1.1) of 96 compounds produced... |
|
Ion-pairing reversed-phase liquid chromatography fractionation in combination with isotope labeling reversed-phase liquid chromatography–mass spectrometry for comprehensive metabolome profiling
J. Chromatogr. A. 1218(23) , 3689-94, (2011) We report a novel two-dimensional (2D) separation strategy aimed at improving the detectability of liquid chromatography mass spectrometry (LC–MS) for metabolome analysis. It is based on the use of io... |
|
In vitro inhibition of salicylic acid derivatives on human cytosolic carbonic anhydrase isozymes I and II.
Bioorg. Med. Chem. 16 , 9101-5, (2008) The inhibition of two human cytosolic carbonic anhydrase (hCA, EC 4.2.1.1) isozymes, hCA I and II, with a series of salicylic acid derivatives was investigated by using the esterase method with 4-nitr... |
Cresotic acid |
2-carboxy-6-methylphenol |
o-cresotic acid |
o-cresotinic |
Hydroxytoluic |
EINECS 209-447-8 |
2-Hydroxy-3-methyl-benzoic acid |
3-Methylsalicylic acid |
Benzoic acid, 2-hydroxy-3-methyl- |
2-ANISIC ACID |
3-methyl salicylic acid |
3-MS |
2-Hydroxy-3-methylbenzoic acid |
cresotinicacid |
MFCD00002431 |